9-130790187-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000372348.9(ABL1):c.137-63877C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 152,158 control chromosomes in the GnomAD database, including 5,026 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 5026 hom., cov: 33)
Consequence
ABL1
ENST00000372348.9 intron
ENST00000372348.9 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.205
Publications
4 publications found
Genes affected
ABL1 (HGNC:76): (ABL proto-oncogene 1, non-receptor tyrosine kinase) This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
ABL1 Gene-Disease associations (from GenCC):
- congenital heart defects and skeletal malformations syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P
- connective tissue disorderInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- bone development diseaseInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.431 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABL1 | NM_007313.3 | c.137-63877C>A | intron_variant | Intron 1 of 10 | NP_009297.2 | |||
| LOC124902288 | XR_007061823.1 | n.247-7393G>T | intron_variant | Intron 2 of 2 | ||||
| LOC124902288 | XR_007061824.1 | n.247-2507G>T | intron_variant | Intron 2 of 2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABL1 | ENST00000372348.9 | c.137-63877C>A | intron_variant | Intron 1 of 10 | 1 | ENSP00000361423.2 | ||||
| ABL1 | ENST00000393293.4 | c.137-63880C>A | intron_variant | Intron 1 of 1 | 5 | ENSP00000376971.4 | ||||
| ENSG00000309617 | ENST00000842460.1 | n.243-7393G>T | intron_variant | Intron 2 of 4 |
Frequencies
GnomAD3 genomes AF: 0.221 AC: 33598AN: 152040Hom.: 5018 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
33598
AN:
152040
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.221 AC: 33649AN: 152158Hom.: 5026 Cov.: 33 AF XY: 0.217 AC XY: 16172AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
33649
AN:
152158
Hom.:
Cov.:
33
AF XY:
AC XY:
16172
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
18087
AN:
41456
American (AMR)
AF:
AC:
3070
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
418
AN:
3472
East Asian (EAS)
AF:
AC:
357
AN:
5182
South Asian (SAS)
AF:
AC:
618
AN:
4828
European-Finnish (FIN)
AF:
AC:
1249
AN:
10596
Middle Eastern (MID)
AF:
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9154
AN:
68020
Other (OTH)
AF:
AC:
453
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1203
2406
3608
4811
6014
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
490
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.